Santen Pharmaceutical Co Ltd  

(Public, TYO:4536)   Watch this stock  
Find more results for rheumatism
1,679.00
+19.00 (1.14%)
Aug 21 - Close
TYO data delayed by 20 mins - Disclaimer
Currency in JPY
Range 1,654.00 - 1,680.00
52 week 1,251.00 - 1,719.00
Open 1,663.00
Vol. 1.12M
Mkt cap 681.99B
P/E 27.89
Div/yield 13.00/1.55
EPS 60.20
Shares 406.19M
Beta     -
Inst. own     -
Nov 2, 2017
Q2 2018 Santen Pharmaceutical Co Ltd Earnings Presentation (Japanese) Add to calendar
Nov 1, 2017
Q2 2018 Santen Pharmaceutical Co Ltd Earnings Release - 3:00PM GMT+9 - Add to calendar
Aug 1, 2017
Q1 2018 Santen Pharmaceutical Co Ltd Earnings Call (Japanese)
Aug 1, 2017
Q1 2018 Santen Pharmaceutical Co Ltd Earnings Call - Webcast
Aug 1, 2017
Q1 2018 Santen Pharmaceutical Co Ltd Earnings Release
Jun 23, 2017
Santen Pharmaceutical Co Ltd Annual Shareholders Meeting
  

Key stats and ratios

Q2 (Jun '17) 2017
Net profit margin 15.93% 11.58%
Operating margin 21.55% 16.31%
EBITD margin - 21.12%
Return on average assets 11.03% 6.80%
Return on average equity 13.95% 8.99%
Employees 3,667 -
CDP Score - C

Address

3-9-19, Shimo-Shinjo, Higashiyodogawa-ku
OSAKA-SHI, OSK 530-8552
Japan
+81-6-63217000 (Phone)
+81-6-63215082 (Fax)

Website links

External links

Description

SANTEN PHARMACEUTICAL CO., LTD. is a Japan-based pharmaceutical company. The ethical pharmaceutical division is engaged in the manufacture, purchase and sale of ethical pharmaceutical products. The general pharmaceutical division is engaged in the manufacture and sale of general pharmaceutical products through its agents. The Others segment has two divisions. The medical equipment division is engaged in the import and sale of optical-related medical equipment, as well as the development, manufacture and sale of intraocular lens. The others division is engaged in the provision of cleaning services for sterilized clothes.

Officers and directors

Akira Kurokawa President, Chief Executive Officer, Representative Director
Age: 64
Kazuo Koshiji Chief Financial Officer, Managing Executive Officer, Chief Director of Finance
Noriaki Yamamoto Chief Information Officer, Executive Officer, Chief Director of Information System
Naveed Shams Chief Scientific Officer, Managing Executive Officer, Chief Director of Research & Development
Masamichi Sato Managing Executive Officer, Chief Compliance Officer, Chief Director of CSR & Internal Control, President of Subsidiary
Takeshi Ito Senior Managing Executive Officer, Director of Pharmaceutical Business, Director
Age: 58
Akihiro Tsujimura Senior Managing Executive Officer, Director of Asia Business, President & Chief Executive Officer of Subsidiary, Director
Age: 49
Shigeo Taniuchi Managing Executive Officer, President of Subsidiary, Director
Age: 43
Atsutoshi Ohta Managing Executive Officer, Chief Director of Human Resources & Organization Development
Takahiro Morita Executive Officer, Senior Director of Pharmaceutical Sales in Pharmaceutical Business Unit